Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction

Drugs and Aging

Volumn 16, Issue 4, 2000, Pages 289-300

  Van Kraaij, Dave J W ^a   Jansen, René W M M ^a   Gribnau, Frank W J ^a   Hoefnagels, Willibrord H L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

AGED; DIURETIC THERAPY; DRUG WITHDRAWAL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE FILLING; HUMAN; LONG TERM CARE; MEDICAL DECISION MAKING; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0034115679     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200016040-00005     Document Type: Review

References (120)

1. 1. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993; 68: 2243-50
2. 2. Thom TJ, Kannel WB. Congestive heart failure: epidemiology and cost of illness. Dis Manage Health Outcomes 1997; 1: 75-83
3. 3. Tresch DD. The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc 1997; 45: 1128-33
4. 4. Litwin SE, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol 1993; 22 Suppl. A: 49A-55A
5. 5. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med 1991; 325: 1557-64
6. 6. Wills P, Fastbom J, Claesson CB, et al. Use of cardiovascular drugs in an older Swedish population. J Am Geriatr Soc 1996; 44: 54-60
7. 7. Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES project. Ann Pharmacother 1996; 30: 589-95
8. 8. Laukkanen P, Heikkinen E, Kauppinen M, et al. Use of drugs by non-institutionalized urban Finns born in 1904-1923 and the association of drug use with mood and self-rated health. Age Ageing 1992; 21: 343-52
9. 9. Delafuente JC, Meuleman JR, Conlin M, et al. Drug use among functionally active aged ambulatory people. Ann Pharmacother 1992; 26: 179-83
10. 10. de Jonge JW. Diuretic drug cessation in general practice: withdrawing diuretic drugs prescribed for ankle oedema [thesis]. Maastricht: Rijksuniversiteit Limburg, 1993
11. 11. Weedle PB, Poston JW, Parish PA. Drug prescribing in residential homes for elderly people in the United Kingdom. Ann Pharmacother 1990; 24: 533-6
12. 12. Jörgensen TM, Isacson DGL, Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacother 1993; 27: 1120-5
13. 13. Van Kraaij DJW, Jansen RWMM, Bruijns E, et al. Diuretic usage and withdrawal patterns in a Dutch geriatric patient population. J Am Geriatr Soc 1997; 45: 918-22
14. 14. Van Kraaij DJW, Jansen RWMM, Gribnau FWJ, et al. Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. Neth J Med 1998; 53: 20-6
15. 15. Kannel WB, Belanger BJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951-7
16. 16. Hlatky MA, Fleg JL, Hinton PC, et al. Physician practice in the management of congestive heart failure. J Am Coll Cardiol 1986; 8: 966-70
17. 17. Croft JB, Giles WH, Roegner RH, et al. Pharmacologic management of heart failure among older adults by office-based physicians in the United States. J Fam Pract 1997; 44: 382-90
18. 18. Van Kraaij DJW, Jansen RWMM, Gier de JJ, et al. Loop diuretics in patients aged 75 years or older: general practitioners assessment of indications and possibilities for withdrawal. Eur J Clin Pharmacol 1998; 54: 323-7
19. 19. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD). South Med J 1995; 88: 514-23
20. 20. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998; 135: 367-72
21. 21. McDermott MM, J Feinglass, Lee P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J 1997; 134: 901-9
22. 22. Guyatt GH. The treatment of heart failure: a methodological review of the literature. Drugs 1986; 32: 538-68
23. 23. Mahabir RN, Loulaufer SF. Clinical evaluation of diuretics in congestive heart failure. Arch Intern Med 1969; 124: 1-7
24. 24. Gillies A, Morgan T, Myers J. Comparison of piretanide and chlorothiazide in the treatment of cardiac failure. Med J Austr 1980; 1: 170-2
25. 25. Abrams J. Intramuscular bumetanide and furosemide in congestive heart failure. J Clin Pharmacol 1981; 21: 673-9
26. 26. Hutcheon D, Nemeth E, Quinlan D. The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure. J Clin Psychopharmacol 1980; 20: 59-68
27. 27. Andrews R, Charlesworth A, Evans A, et al. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. Eur Heart J 1997; 18: 852-7
28. 28. Patterson JH, Adams Jr KF. Applefeld MM, et al. Oral torsemide in patients with chronic congestive heart failure: effects on bodyweight, edema, and electrolyte excretion. Pharmacotherapy 1994; 14: 514-21
29. 29. Salisbury PF, Cross CE, Rieben PA. Acute ischemia of inner layers of ventricular wall. Am Heart J 1963; 66: 650-6
30. 30. Taylor SH. Diuretics in heart failure: Some knowns and unknowns. J Cardiovasc Pharmacol 1993; 22 Suppl. 3: S40-50
31. 31. Larsen FF. Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction. Eur Heart J 1988; 9: 125-31
32. 32. Nelson GIC, Ahuja RC, Silke B, et al. Haemodynamic effects of frusemide and its influence on repetitive volume loading in acute myocardial infarction. Eur Heart J 1983; 4: 706-11
33. 33. Mond H, Hunt D, Sloman G. Haemodynamic effects of frusemide in patients suspected of having acute myocardial infarction. Br Heart J 1974; 36: 44-53
34. 34. Kiely J, Kelly DT, Taylor DR, et al. The role of furosemide in the treatment of left ventricular systolic dysfunction associated with acute myocardial infarction. Circulation 1973; 58: 581-7
35. 35. Davidson RM. Hemodynamic effects of furosemide in acute myocardial infarction [abstract|. Circulation 1971; 54 Suppl. 11: 156
36. 36. Tattersfield AE, McNicol MW, Sillelt RW. Haemodynamic effects of intravenous furosemide in patients with myocardial infarction and left ventricular failure. Clin Sci Mol Med 1974; 46: 253-64
37. 37. Franciosa JA, Silverstein SR, Wilen M. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure. Clin Pharmacol Ther 1982; 32: 62-9
38. 38. Ikram H, Chan W, Espiner EA, et al. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci 1980; 59: 443-9
39. 39. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 1985; 103: 1-6
40. 40. Nelson GIC, Ahuja RC, Silke B, et al. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction. Lancet 1983; 1: 730-3
41. 41. Northridge D. Frusemide or nitrates for acute heart failure? Lancet 1996; 347: 667-8
42. 42. Nishijima H, Yasuda H, Ito K, et al. Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure: diuretics, low salt diet and bed rest. Jap Heart J 1964; 25: 571-85
43. 43. Anand IS, Veall N, Kalra GS, et al. Treatment of heart failure with diuretics: body compartments, renal function and plasma hormones. Eur Heart J 1989; 10: 445-50
44. 44. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-9
45. 45. Massie BM, Ports T, Chatterjee K, et al. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation 1981; 63: 269-78
46. 46. Packer M. Treatment of chronic heart failure. Lancet 1992; 340: 92-5
47. 47. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990; 82: 1724-9
48. 48. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23
49. 49. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302
50. 50. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17
51. 51. Pfeffer MA, Braunwald E, Moye LA, for the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-77
52. 52. Yusuf S, Nicklas JM, Timmis G, for the SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91
53. 53. Kitzman DW, Higginbotham MB, Cobb FR, et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991; 17: 1065-72
54. 54. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994; 271: 1276-80
55. 55. Ruzumna P, Gheorghiade M, Bonow RO. Mechanisms and management of heart failure due to diastolic dysfunction. Curr Opin Cardiol 1996; 11: 269-75
56. 56. Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc 1995; 43: 1035-42
57. 57. Lorell BH. Significance of diastolic dysfunction of the heart. Ann Rev Med 1991; 42: 411-36
58. 58. Josephs W, Odenthal HJ, Lenga P, et al. Diastolische linksventrikuläre Dysfunktion - Bedeutung für die Differentialdiagnostik und-therapie der Herzinsuffizienz im Alter. Z Gerontol 1992; 25: 94-100
59. 59. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032-6
60. 60. Cohn JN, Johnson G, and the Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HeFT study. Circulation 1990; 81 Suppl. III: III48-III53
61. 61. Dougherty AH, Naccarelli GV, Gray EL, et al. Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-82
62. 62. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-74
63. 63. Wong WF, Gold S, Fukuyama O, et al. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989; 63: 1526-8
64. 64. Aronow WS, Ahn C, Kronszon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 1990; 66: 1257-9
65. 65. Taffet GE, Teasdale TA, Bleyer AJ, et al. Survival of elderly men with congestive heart failure. Age Ageing 1992; 21: 49-55
66. 66. Ramachandran SV, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-74
67. 67. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19: 990-1003
68. 68. Galderisi M, Benjamin EJ, Evans JC, et al. Intra-and inter-observer reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). Am J Cardiol 1992; 70: 1341-6
69. 69. Rakowski H. Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996; 9: 736-60
70. 70. Taylor R, Waggoner AD. Doppler assessment of left ventricular diastolic function: a review. J Am Soc Echocardiogr 1992; 5: 603-12
71. 71. Echeverria HH, Bilsker MS, Myerburg RJ, et al. Congestive heart failure: echocardiographic insights. Am J Med 1983; 75: 750-5
72. 72. Aronow WS. Echocardiography should be performed in all elderly patients with congestive heart failure. J Am Geriatr Soc 1994; 42: 1300-2
73. 73. Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327: 1735-9
74. 74. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med 1992; 117: 502-10
75. 75. Jansen RWMM, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122: 286-95
76. 76. Nagano R, Masuyama T, Lee JM, et al. Prediction of changes in cardiac output in association with preload reduction therapy in patients with hypertensive heart failure. Cardiovasc Drugs Ther 1997; 11: 49-56
77. 77. Van Kraaij DJW, Jansen RWMM, Bouwels LHR, et al. Furosemide withdrawal improves postprandial hypotension in elderly heart failure patients with preserved left ventricular systolic function. Arch Int Med 1999; 159: 1599-605
78. 78. Van Kraaij DJW, Jansen RWMM, Bouwels LHR, et al. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular ejection systolic function. Am J Cardiol. In press
79. 79. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944-8
80. 80. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701-7
81. 81. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51-9
82. 82. Cooper JW. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc 1996; 44: 194-7
83. 83. Phillips PA, Rolls BJ, Ledingham JGG, et al. Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 1984; 311: 753-9
84. 84. Crane MG, Harris JJ. Effect of aging on renin activity and aldosterone excretion. J Lab Clin Med 1976; 87: 947-59
85. 85. Kirkland J, Lye M, Goddard C, et al. Plasma arginine vasopressin in dehydrated elderly patients. Clin Endocrinol 1984; 20: 451-6
86. 86. Epstein M, Hollenberg NK. Age as a determinant of renal sodium conservation in normal men. J Lab Clin Med 1976; 87: 411-7
87. 87. Rowe JW, Shock NW, DeFronzo RA. The influence of age on the renal response to water deprivation in man. Nephron 1976; 17: 270-8
88. 88. Shannon RP, Wei JY, Rosa RM, et al. The effect of age and sodium depletion on cardiovascular response to orthostasis. Hypertension 1986; 8: 438-43
89. 89. Snyder NA, Feigal DW, Arieff AL. Hypernatremia in elderly patients: a heterogeneous, morbid, and iatrogenic entity. Ann Intern Med 1987; 107: 309-18
90. 90. Weinberg AD, Minaker KL, and the Council on Scientific Affairs of the American Medical Association. Dehydration: evaluation and management in older adults. JAMA 1995; 274: 1552-6
91. 91. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998; 279: 585-92
92. 92. Heckbert SR, Longstreth WT, Psaty BM, et al. The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults. J Am Geriatr Soc 1997; 45: 1423-33
93. 93. Suissu S, Bourgault C, Barkun A, et al. Antihypertensive drugs and the risk of gastrointestinal bleeding. Am J Med 1998; 105: 230-5
94. 94. Grinstead WC, Francis MJ, Marks GF, et al. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 881-6
95. 95. Walma EP, Hoes AW, Dooren van AW, et al. Withdrawal of long term diuretic medication in elderly patients: a double-blind randomised trial. BMJ 1997; 315: 464-8
96. 96. Levinson PD, Khatri IM, Freis ED. Persistence of normal blood pressure after withdrawal of drug treatment in mild hypertension. Ann Intern Med 1982; 142: 2265-8
97. 97. Ekbom T, Lindholm LH, Odén A. A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. J Intern Med 1994; 235: 581-8
98. 98. van Kruijsdijk M. Hypertensie opnieuw gemeten [thesis]. Department of General Practice and Social Medicine. Nijmegen: Catholic University, 1991
99. 99. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Return of elevated blood pressure after withdrawal of antihypertensive drugs. Circulation 1975; 51: 1107-13
100. 100. Fagerberg B, Wikstrand J, Berglund G, et al. Withdrawal of antihypertensive drug treatment: time-course for redevelopment of hypertension and effects upon left ventricular mass. J Hypertens 1992; 10: 587-93
101. 101. Medical Research Council Working Party on Mild Hypertension. Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. BMJ 1986; 293: 988-93
102. 102. Taggart AJ, McDevitt DG. Diuretic withdrawal: a need for caution. Curr Med Res Opin 1983; 8: 501-8
103. 103. Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991; 90: 353-9
104. 104. Karon BL. Diagnosis and outpatient management of congestive heart failure. Mayo Clin Proc 1995; 70: 1080-5
105. 105. Butman SM, Ewy GA, Standen JR, et al. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 1993; 22: 968-74
106. 106. Badgett RG, Mulrow CD, Otto PM, et al. How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 1996; 11: 625-34
107. 107. Van Kraaij DJW, Schuurmans MMJ, Jansen RWMM, et al. Use of Valsalva's manoeuvre to identify haemodialysis patients at risk for congestive heart failure. Nephrol Dial Transplant 1998; 13: 1518-23
108. 108. Van Kraaij DJW, Jansen RWMM, Bouwels LHR, et al. Use of Valsalva's maneuver to detect early recurrence of congestive heart failure in a randomised trial of furosemide withdrawal in elderly patients. J Am Geriatr Soc 1999; 47: 1384-5
109. 109. Van Kraaij DJW, Jansen RWMM, Hoefnagels WJL, et al. Monitoring hypovolemia in healthy elderly subjects by measuring blood pressure response to Valsalva's maneuver. Geriatr Urol Nephrol 1999; 9: 73-99
110. 110. Magnani B, Magelli C, for the Multicentre Research Group on Mild Heart Failure. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial. Postgrad Med J 1986; 62 Suppl. 1: 153-8
111. 111. Magnani B. Converting enzyme inhibition and heart failure. Am J Med 1988; 84 Suppl. 3A: 87-91
112. 112. Richardson A, Bayliss J, Scriven AJ, et al. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 1987; 11: 709-11
113. 113. Agency for Health Care Policy and Research (AHCPR). Heart failure: evaluation and treatment of patients with left ventricular systolic dysfunction. J Am Geriatr Soc 1998; 46: 525-9
114. 114. Cleland JGF, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet 1998; 352: S119-28
115. 115. Remme WJ. Present treatment options in congestive heart failure. Heart 1998; 79 Suppl. 2: S24-8
116. 116. Cohn JN. The management of chronic heart failure. N Engl J Med 1996; 335: 490-8
117. 117. Williams JF, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evalualion and Management of Heart Failure). J Am Coll Cardiol 1995; 26: 1376-98
118. 118. Centraal Begeleidingsorgaan voor de Intercollegiate Toetsing (CBO) Consensus Hartfalen. Utrecht: CBO; 1994
119. 119. Swedish Medical Products Agency. Pharmacological treatment of heart failure. Uppsala: Lakemedelsverket, 1993
120. 120. Aronow WS. Treatment of congestive heart failure in older persons. J Am Geriatr Soc 1997; 45: 1252-8